期刊文献+

敲除TSPAN1抑制人结肠癌细胞的生长和侵袭 被引量:3

Knockout of TSPAN1 Inhibits Tumor Growth and Metastasis of Human Colon Cancer
下载PDF
导出
摘要 目的 TSPAN1能够影响人结直肠癌细胞的增殖、扩散和侵袭。方法用腺病毒同源重组的方法建立TSPAN1缺失的人结直肠癌HCT116细胞系,CCK-8、克隆形成、划痕和Transwell实验分别检测缺失TSPAN1的细胞生长速率、成瘤、迁移和侵袭能力。裸鼠成瘤实验检测TSPAN1对肿瘤扩散的影响。双荧光素酶实验验证TSPAN1对雌激素受体和TGF-β受体活性的影响。结果缺失TSPAN1的HCT116细胞的生长速率、成瘤、迁移和侵袭能力显著降低。在裸鼠中分别注射野生型和缺失TSPAN1的HCT116细胞,后者肿瘤扩散变慢,并且裸鼠的成活率提高。过表达TSPAN1能够激活雌激素受体和TGF-β受体。结论 TSPAN1可能通过雌激素受体和TGF-β受体通路来调节细胞增殖和侵袭过程,并且为治疗结直肠癌提供了潜在的新靶标。 Objective TSPAN1 affects human colon tumor cells on proliferation, migration and invasion. Methods We established a TSPAN1 -deficient HCT116 cell line by adenovirus homologous recombination. Then we used CCK -8, colony formation, wound healing and Transwell assays to detect the rate of cell proliferation and the ability of tumor formation, migration and invasion of TSPAN1 - deficient cells. With nude mouse tumorigenicity assay, we also tested the effect of TSPAN1 on the spread of tumor. Dual luciferase experi- ment validated that TSPAN1 effected the activity of estrogen receptor and TGF - beta receptors. Results The rate of cell proliferation and the ability of tumor formation, migration and invasion were significantly reduced in TSPAN1 - deficient cells. We also injected HCT116 and TSPAN1 -deficient HCT116 ceils into athymic nude mice via the tail vein, and found a dramatic reduction of tumor cell migration. Mice injected with TSPAN1 - deficient cells showed prolonged survival. Overexpression of TSPAN1 could active estrogen receptor and transforming growth factor - β receptor. Conclusion TSPAN1 might regulate cell migration and invasion through these pathways. Thus, we suggest that TSPAN1 may be a novel therapeutic target for colon cancer treatment.
出处 《医学研究杂志》 2016年第1期29-33,共5页 Journal of Medical Research
基金 国家自然科学基金资助项目(81270306 30971499)
关键词 TSPAN1 结直肠癌 迁移 侵袭 TGF—β TSPAN1 Colon cancer Migration Invasion TGF- β
  • 相关文献

参考文献1

二级参考文献25

  • 1Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
  • 2Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130
  • 3Ji BT, Devesa SS, Chow WH, Jin F, Gao YT. Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev 1998; 7: 661-666
  • 4You WC, Jin F, Devesa S, Gridley G, Schatzkin A, Yang G, Rosenberg P, Xiang YB, Hu YR, Li Q. Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes. J Cancer Epidemiol Prev 2002; 7: 143-146
  • 5Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M, Fuchs CS. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 2006; 19: 59-68
  • 6Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A. Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Mod Pathol 2007; 20: 331-338
  • 7Givalos N, Gakiopoulou H, Skliri M, Bousboukea K, Konstantinidou AE, Korkolopoulou P, Lelouda M, Kouraklis G, Patsouris E, Karatzas G. Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Mod Pathol 2007; 20: 159-166
  • 8Denkert C, Koch I, von Keyserlingk N, Noske A, Niesporek S, Dietel M, Weichert W. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 2006; 19: 1261-1269
  • 9Murata M, Iwao K, Miyoshi Y, Nagasawa Y, Ohta T, Shibata K, Oda K, Wada H, Tominaga S, Matsuda Y, Ohsawa M, Nakamura Y, Shimano T. Molecular and biological analysis of carcinoma of the small intestine: beta-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype. Am J Gastroenterol 2000; 95: 1576-1580
  • 10Debruyne PR, Bruyneel EA, Karaguni IM, Li X, Flatau G, Müller O, Zimber A, Gespach C, Mareel MM. Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene 2002; 21: 6740-6750

共引文献5

同被引文献20

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部